Matching trials
1,853 results
- DIAS-2Independent statistical analysis of the randomized phase 3 DIAS-2 trial of desmoteplase in acute ischemic stroke, including its design, functional endpoints, planned statistical analysis, and interpretation.
- Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DIGIndependent statistical analysis of the randomized phase 3 DIG trial of digoxin versus placebo in acute heart failure, including its design, 30-day mortality and rehospitalization endpoint, planned statistical methodology, and interpretation.
- DIGESTIndependent statistical analysis of Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01285557).
- DIRECTComplete statistical analysis of DIRECT (NCT00252694), a randomized phase 3 trial of candesartan in type 2 diabetes, including trial design, diabetic retinopathy endpoint definition, log-rank analysis, hazard ratio, confidence interval, p-value, and…
- DIRECTComplete statistical analysis of the DIRECT phase 3 trial of candesartan in participants with type 1 diabetes, including trial design, diabetic retinopathy progression, time-to-event methodology, hazard ratio interpretation, and safety.
- DIRECTComplete statistical analysis of the DIRECT trial of candesartan versus placebo in type 1 diabetes, including trial design, ETDRS retinopathy endpoint, log-rank analysis, hazard ratio, confidence interval, p-value, safety, and statistical interpretation.
- DIRECTComplete statistical analysis of DIRECT, a randomized phase 3 trial of denosumab versus placebo in Japanese patients with osteoporosis, including vertebral fracture, non-vertebral fracture, and hip fracture analyses.
- DISCOVERIndependent statistical analysis of the DISCOVER phase 3 trial evaluating F/TAF versus F/TDF for HIV-1 pre-exposure prophylaxis, including non-inferiority testing, rate-ratio analysis, BMD, renal biomarkers, and statistical methodology.
- DISSOLVE IIndependent statistical analysis of A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DKP 3M SCIndependent statistical analysis of Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DolphinIndependent statistical analysis of A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB): primary endpoint results, effect estimate with confidence…
- Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock: Complete Statistical AnalysisIndependent statistical analysis of Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019): Complete Statistical AnalysisIndependent statistical analysis of Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation: Complete Statistical AnalysisIndependent statistical analysis of Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01078909).
- Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013): Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843): Complete Statistical AnalysisIndependent statistical analysis of Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843): primary endpoint results, effect estimate with confidence interval,…
- Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures: Complete Statistical AnalysisIndependent statistical analysis of Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy: primary endpoint results, effect estimate with confidence…
- DREAMM-3Independent statistical analysis of DREAMM-3, a randomized phase 3 trial comparing single-agent belantamab mafodotin with pomalidomide plus low-dose dexamethasone in relapsed/refractory multiple myeloma.
- DREAMM-7Independent statistical analysis of the DREAMM-7 phase 3 China subpopulation trial evaluating belantamab mafodotin, bortezomib and dexamethasone versus daratumumab, bortezomib and dexamethasone in relapsed/refractory multiple myeloma.
- DREAMM-8Independent statistical analysis of DREAMM-8, a randomized phase 3 trial of belantamab mafodotin plus pomalidomide and dexamethasone versus bortezomib plus pomalidomide and dexamethasone in multiple myeloma.
- DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]: Complete Statistical AnalysisIndependent statistical analysis of DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]: primary endpoint results, effect estimate…
- DUAL™Independent statistical analysis of A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and…
- DUAL™ IComplete statistical analysis of DUAL™ I, a randomized phase 3 trial comparing insulin degludec/liraglutide, insulin degludec, and liraglutide in subjects with type 2 diabetes, including ANCOVA, non-inferiority, superiority, confidence intervals, missing-data handling,…
- Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose: Complete Statistical AnalysisIndependent statistical analysis of Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH): Complete Statistical AnalysisIndependent statistical analysis of Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- DW224-III-3Independent statistical analysis of A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DYNAGITOIndependent statistical analysis of DYNAGITO (NCT02296138), a phase 3 trial of tiotropium/olodaterol 5/5 µg versus tiotropium 5 µg for moderate to severe COPD exacerbations: negative binomial rate ratios, 99% confidence intervals, a…
- Dysport® Adult Upper Limb Spasticity Extension Study: Complete Statistical AnalysisIndependent statistical analysis of Dysport® Adult Upper Limb Spasticity Extension Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01313312).
- Dysport® Pediatric Lower Limb Spasticity Follow-on Study: Complete Statistical AnalysisIndependent statistical analysis of Dysport® Pediatric Lower Limb Spasticity Follow-on Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01251380).
- DYSTANCE 51Independent statistical analysis of Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- E1199An independent statistical analysis of E1199, a randomized phase 3 trial of combination chemotherapy in women with stage II or stage IIIA breast cancer that has spread to the lymph nodes. The…
- e3Complete statistical analysis of the e3 phase 3 trial evaluating everolimus versus placebo with hormone therapy in breast cancer, including trial design, time-to-event endpoints, hazard ratios, confidence intervals, statistical methodology, and interpretation.
- E5103Independent statistical analysis of E5103 (NCT00433511), a randomized phase 3 trial evaluating doxorubicin, cyclophosphamide, and paclitaxel with or without bevacizumab in breast cancer.
- EARNESTIndependent statistical analysis of the EARNEST phase 3 trial evaluating second-line HIV therapy strategies, including trial design, endpoints, statistical methodology, and interpretation.
- EASEComplete statistical analysis of the randomized phase 3 EASE trial evaluating single-dose fosaprepitant versus aprepitant for prevention of chemotherapy-induced nausea and vomiting, including non-inferiority methodology, risk differences, confidence intervals, and safety.
- EASEIndependent statistical analysis of Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EASE SBS 1Independent statistical analysis of Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EASSIIndependent statistical analysis of EASSI - Evaluation of the Safety of Self-Administration With Icatibant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00997204).
- EBBINGHAUSComplete statistical analysis of the EBBINGHAUS phase 3 trial of evolocumab versus placebo for cognitive outcomes in high cardiovascular risk subjects with dyslipidemia, including MMRM methodology, non-inferiority analysis, confidence intervals, and safety…
- ECHELON-2Independent statistical analysis of ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas: primary endpoint results, effect estimate with confidence…
- EDENIndependent statistical analysis of EDEN (NCT00883948), a phase 3 randomized trial comparing minimal trophic feeding with full feeding in people with acute lung injury or acute respiratory distress syndrome.
- EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD): Complete Statistical AnalysisIndependent statistical analysis of EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02305797).
- EDITION IVIndependent statistical analysis of Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease: Complete Statistical AnalysisIndependent statistical analysis of Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease: primary endpoint results, effect estimate with confidence interval,…
- EDUCATEIndependent statistical analysis of Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EEG Synchronized TMS Trial for Depression: Complete Statistical AnalysisIndependent statistical analysis of EEG Synchronized TMS Trial for Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03421808).
- Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate: Complete Statistical AnalysisIndependent statistical analysis of Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate: primary endpoint results, effect estimate with confidence interval,…
- Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3: Complete Statistical AnalysisIndependent statistical analysis of Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3: primary endpoint results, effect estimate with confidence interval,…